Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. [electronic resource]
- Journal of the National Cancer Institute Mar 2003
- 484-6 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.